Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
快手-W
01024
5
京东健康
06618
| (Q3)2025/09/30 | (Q2)2025/06/30 | (Q1)2025/03/31 | (FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | -77.95%682.1万 | 1,517.76%1,876.6万 | 819.33%437.6万 | 208.55%4,506.71万 | 18.46%1,249.6万 | 49,995.16%3,093.5万 | -58.56%116万 | -63.91%47.6万 | -44.51%1,460.6万 | 85.10%1,054.9万 |
| 主营业务成本 | 200.23%3,353.07万 | -40.03%1,116.83万 | ||||||||
| 毛利 | 235.59%1,153.64万 | -55.34%343.77万 | ||||||||
| 营业费用 | -74.07%615.2万 | 555.84%1,498.6万 | 166.03%404.1万 | 18.40%542.74万 | 12.21%1,250.8万 | 4,832.85%2,372.7万 | -22.17%228.5万 | 27.65%151.9万 | -33.02%458.41万 | 183.73%1,114.7万 |
| 其他营业费用 | -73.21%649.5万 | 558.18%1,633.6万 | 156.44%456.2万 | 3.19%662.79万 | 6.04%1,269.8万 | 1,990.00%2,424.4万 | -21.23%248.2万 | 36.95%177.9万 | -14.99%642.32万 | 191.82%1,197.5万 |
| 其他营业收入总额 | -33.66%34.3万 | 585.28%135万 | 100.38%52.1万 | -34.73%120.05万 | -77.05%19万 | -23.86%51.7万 | -8.37%19.7万 | 138.53%26万 | 158.32%183.92万 | 205.57%82.8万 |
| 营业利润 | -90.72%66.9万 | 436.00%378万 | 132.12%33.5万 | 632.88%610.9万 | 97.99%-1.2万 | 1,427.44%720.8万 | -721.17%-112.5万 | -908.53%-104.3万 | -234.31%-114.64万 | -253.90%-59.8万 |
| 营业外利息收入与支出净额 | -70.83%-16.4万 | -167.57%-19.8万 | -775.00%-14万 | -42.09%-21.63万 | -172.73%-3万 | -357.14%-9.6万 | -39.62%-7.4万 | 76.12%-1.6万 | -160.23%-15.22万 | 51.11%-1.1万 |
| 营业外利息支出 | 70.83%16.4万 | 167.57%19.8万 | 775.00%14万 | 42.09%21.63万 | 172.73%3万 | 357.14%9.6万 | 39.62%7.4万 | -76.12%1.6万 | 160.23%15.22万 | -51.11%1.1万 |
| 投资净收益 | ||||||||||
| 被指定为现金流套期的金融工具损益 | ||||||||||
| 终止确认可供出售金融资产损益 | ||||||||||
| 联营企业及其他参股权益产生的收益 | ||||||||||
| 特殊收入(费用) | -100万 | 0 | ||||||||
| 减:勾销 | ---- | ---- | ---- | --100万 | ---- | ---- | ---- | ---- | --0 | ---- |
| 其他营业外收入(费用) | ||||||||||
| 税前利润 | -92.90%50.5万 | 398.75%358.2万 | 118.41%19.5万 | 476.75%489.26万 | 93.10%-4.2万 | 1,360.99%711.2万 | -531.05%-119.9万 | -1,808.06%-105.9万 | -263.34%-129.86万 | -266.37%-60.9万 |
| 所得税 | -61.16%52.4万 | 3,372.55%177.1万 | 107.69%16.2万 | 93.40%131.61万 | -38.10%3.9万 | 953.91%134.9万 | -56.78%5.1万 | -80.50%7.8万 | 0.11%68.05万 | -32.10%6.3万 |
| 除税后利润 | -100.33%-1.9万 | 244.88%181.1万 | 102.90%3.3万 | 280.71%357.65万 | 87.95%-8.1万 | 932.80%576.3万 | -305.84%-125万 | -236.39%-113.7万 | -1,816.92%-197.91万 | -345.91%-67.2万 |
| 持续经营利润 | -100.33%-1.9万 | 244.88%181.1万 | 102.90%3.3万 | 280.71%357.65万 | 87.95%-8.1万 | 932.80%576.3万 | -305.84%-125万 | -236.39%-113.7万 | -1,816.92%-197.91万 | -345.91%-67.2万 |
| 归属于少数股东的净利润 | -115.87%-44.9万 | 84.62%-2.6万 | -154.90%-39万 | -30.55%-71.69万 | -72.11%-25.3万 | -388.89%-20.8万 | 29.88%-16.9万 | 34.62%-15.3万 | -45.41%-54.91万 | -77.89%-14.7万 |
| 归属于母公司的净利润 | -92.80%43万 | 270.77%184.6万 | 142.99%42.3万 | 400.23%429.34万 | 132.76%17.2万 | 881.54%597.1万 | -1,513.43%-108.1万 | -846.15%-98.4万 | -390.12%-143万 | -247.51%-52.5万 |
| 优先股派息 | ||||||||||
| 其他优先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 归属于普通股股东的净利润 | -92.80%43万 | 270.77%184.6万 | 142.99%42.3万 | 400.23%429.34万 | 132.76%17.2万 | 881.54%597.1万 | -1,513.43%-108.1万 | -846.15%-98.4万 | -390.12%-143万 | -247.51%-52.5万 |
| 总派息金额 | ||||||||||
| 基本每股收益 | -93.35%0.0035 | 249.07%0.0161 | 141.38%0.0036 | 398.44%0.0382 | 130.00%0.0015 | 52,700.00%0.0526 | -2,060.00%-0.0108 | -866.67%-0.0087 | -390.91%-0.0128 | -256.25%-0.005 |
| 稀释每股收益 | -93.35%0.0035 | 249.07%0.0161 | 141.38%0.0036 | 398.44%0.0382 | 130.00%0.0015 | 52,700.00%0.0526 | -2,060.00%-0.0108 | -866.67%-0.0087 | -397.67%-0.0128 | -261.29%-0.005 |
| 每股派息 | 0 | 0 | 0 | 25.00%0.025 | 25.00%0.025 | 0 | 0 | 0 | 0.00%0.02 | 0.00%0.02 |
| 会计准则 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY:Financial Year 年度报告,相当于上市公司向SEC披露的10-K文件。
Q:Quarter 季度报告,相当于上市公司向SEC披露的10-Q文件,其中Q1、Q2、Q3、Q4为单季报,跨度为3个月;Q6、Q9为累计季报,Q6为6个月,Q9为9个月。